Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Mussetti A, Salas MQ, Condom M, Antonio M, Ochoa C, Ivan I, Jimenez Ruiz-De la Torre D, Sanz Linares G, Ansoleaga B, Patinño-Gutierrez B, Jimenez-Prat L, Parody R, Sureda-Balari A
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Prospective Pilot Study of Telehealth as Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID-19 Pandemic
Alberto Mussetti;
Maria Queralt Salas;
Maria Condom;
Maite Antonio;
Cristian Ochoa;
Iulia Ivan;
David Jimenez Ruiz-De la Torre;
Gabriela Sanz Linares;
Belen Ansoleaga;
Beatriz Patinño-Gutierrez;
Laura Jimenez-Prat;
Rocio Parody;
Ana Sureda-Balari
ABSTRACT
Patients receiving hematopoietic cell transplantation are at increased risk of infectious complications. A higher mortality was shown for these patients affected by COVID19. In this prospective study, we developed and tested a telemedicine platform to improve the domiciliary follow-up of patients who had received a transplant. Daily monitoring of vital signs, symptoms and psychological status was performed through a mobile phone application and clinically validated medical devices. Sixteen patients were enrolled for this proof-of-concept study. Thirty-eight percent of transplants were autologous and sixty-two percent were allogeneic. Four patients were not able to use the app due to their inability in using smartphone applications. Patients’ adherence in reporting study data was acceptable. The subjective perception of the study was considered positive from the majority of patients. We showed how to implement a specific telemedicine platform in the setting of transplanted patients with promising results.
Citation
Please cite as:
Mussetti A, Salas MQ, Condom M, Antonio M, Ochoa C, Ivan I, Jimenez Ruiz-De la Torre D, Sanz Linares G, Ansoleaga B, Patinño-Gutierrez B, Jimenez-Prat L, Parody R, Sureda-Balari A
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study